SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001140361-24-010109
Filing Date
2024-02-28
Accepted
2024-02-28 16:30:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2825
  Complete submission text file 0001140361-24-010109.txt   4657
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Subject) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39329 | Film No.: 24695961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NOGRA GROUP SICAF-SIF S.A. 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227
Business Address C/O NOGRA GROUP SICAF-SIF S.A. 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-2227 352 26200068
GG 1978 SICAF SIF S.A. - GG Strategic (Reporting) CIK: 0001814890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 144